Parataxis Korea, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 468.00
-31.00 (-6.21%)
At close: Apr 2, 2026
Parataxis Korea Revenue
Parataxis Korea had revenue of 10.10M KRW in the twelve months ending September 30, 2025, up 834.35% year-over-year. In the year 2024, Parataxis Korea had annual revenue of 2.18M, down -97.82%.
Revenue (ttm)
10.10M
Revenue Growth
+834.35%
P/S Ratio
4,727.28
Revenue / Employee
480.84K
Employees
21
Market Cap
47.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.18M | -97.82M | -97.82% |
| Dec 31, 2023 | 100.00M | -2.92B | -96.69% |
| Dec 31, 2022 | 3.02B | 1.10B | 57.15% |
| Dec 31, 2021 | 1.92B | -4.42B | -69.65% |
| Dec 31, 2020 | 6.34B | -51.94B | -89.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| J2KBIO | 32.97B |
| Naturalendo Tech | 22.23B |
| NGeneBio | 21.24B |
| Ark Solutions | 16.08B |
| PanGen Biotech | 13.42B |
| ADBiotech | 12.90B |
| MOA Life Plus | 11.22B |
| HLB Pep | 4.96B |